Stay updated on IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page.

Latest updates to the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page
- Check5 days agoChange DetectedThe page’s revision label has been updated to a newer release (v3.5.3), replacing the previous revision (v3.5.2).SummaryDifference0.1%

- Check12 days agoChange DetectedRevision: v3.5.2 replaces the previous v3.5.0.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check41 days agoChange DetectedThe page now shows an updated revision label to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check76 days agoChange DetectedAddition of Revision: v3.4.2 and removal of the generic government funding status notice (and the prior Revision: v3.4.1) appear to be administrative site maintenance updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check83 days agoChange DetectedSite-wide notices about government funding and NIH Clinical Center operating status are displayed, and the page version has been updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page.